ロード中...
Activities of Mutant Prevention Concentration-Targeted Moxifloxacin and Levofloxacin against Streptococcus pneumoniae in an In Vitro Pharmacodynamic Model
The differential effects of moxifloxacin and levofloxacin on the development of resistance in four Streptococcus pneumoniae isolates were examined by using an in vitro pharmacodynamic model. Therapeutic regimens (moxifloxacin: peak, 4.5 μg/ml; half-life [t(1/2)], 12 h; and levofloxacin: peak, 6 μg/m...
保存先:
主要な著者: | , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
American Society for Microbiology
2003
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC166082/ https://ncbi.nlm.nih.gov/pubmed/12878526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.8.2606-2614.2003 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|